# EDGAR Filing Document

**Accession Number:** 0001140859
**File Stem:** 0001140859-23-000021
**Filing Date:** 2023-1
**Character Count:** 5727
**Document Hash:** 0f2531931a9fb34a10463bf1bd1f05fd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140859-23-000021.hdr.sgml**: 20230126

**ACCESSION NUMBER**: 0001140859-23-000021

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20230123

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**FILED AS OF DATE**: 20230126

**DATE AS OF CHANGE**: 20230126

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AMERISOURCEBERGEN CORP
- **CENTRAL INDEX KEY:** 0001140859
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
- **IRS NUMBER:** 233079390
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-16671
- **FILM NUMBER:** 23557771

**BUSINESS ADDRESS:**
- **STREET 1:** 1 WEST FIRST AVENUE
- **CITY:** CONSHOHOCKEN
- **STATE:** PA
- **ZIP:** 19428
- **BUSINESS PHONE:** 6107277000

**MAIL ADDRESS:**
- **STREET 1:** 1 WEST FIRST AVENUE
- **CITY:** CONSHOHOCKEN
- **STATE:** PA
- **ZIP:** 19428

?xml version="1.0" ? abc-20230123

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

_________________________________

**FORM 8-K** 

_________________________________

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): January 23, 2023

&nbsp;&nbsp;&nbsp;&nbsp;_________________________________

**AmerisourceBergen Corporation**

(Exact name of registrant as specified in its charter)

**_________________________________**

Commission File Number: **1-6671** 

---

| | | | |
|:---|:---|:---|:---|
| **Delaware** | **Delaware** | **Delaware** | **23-3079390** |
| (State or other jurisdiction of | (State or other jurisdiction of | (State or other jurisdiction of | (I.R.S. Employer |
| incorporation or organization) | incorporation or organization) | incorporation or organization) | Identification No.) |
| **1 West First Avenue** | **Conshohocken** | **PA** | **19428-1800** |
| (Address of principal executive offices) | (Address of principal executive offices) | (Address of principal executive offices) | (Zip Code) |

---

**(610) 727-7000** 

(Registrant's telephone number, including area code)

**Not Applicable**

(Former name or former address, if changed since last report.)

_________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

**☐** Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

**☐** Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

**☐** Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

**☐** Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | | |
|:---|:---|:---|:---|
| **<u>Title of each class</u>** | **<u>Trading Symbol(s)</u>** | **<u>Name of exchange on which registered</u>** | **<u>Name of exchange on which registered</u>** |
| Common stock | ABC | New York Stock Exchange | (NYSE) |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company **☐** 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

------

**Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

On January 23, 2023, two members of the Board of Directors (the "Board") of AmerisourceBergen Corporation (the "Company"), Jane E. Henney, M.D. and Michael J. Long, each informed the Company of their intent to retire as directors at the upcoming Annual Meeting of Stockholders to be held on March 9, 2023 (the "Annual Meeting"). Dr. Henney and Mr. Long each indicated an intent to continue to serve as a director of the Company until the Annual Meeting, and advised the Company that there were no disagreements between the Company and them relative to their intent to retire from the Board. Following the Annual Meeting, the Board will have 10 members.

Dr. Henney has served as a director since 2002 and currently serves as the Lead Independent Director, a member of the Board's Executive Committee and an ex-officio member of the Board's other standing Committees. Mr. Long has served as a director since 2006 and currently serves as Chair of the Merger Integration Committee and as a member of the Board's Executive Committee and Governance, Sustainability & Corporate Responsibility Committee.

------

<u>SIGNATURES</u>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | | AMERISOURCEBERGEN CORPORATION | AMERISOURCEBERGEN CORPORATION |
| Date: | January 26, 2023 | By: | /s/ Elizabeth S. Campbell |
|  |  | Name: | Elizabeth S. Campbell |
|  |  | Title: | Executive Vice President & Chief Legal Officer |

---